bpc 157 clinical trial recruiting 2025 BPC-157: What the Science Actually Says RFK Jr pushes for FDA

While kidney function is the main factor affecting dose adjustments, always inform your doctor about other health conditions and medications to avoid interactions

Unlike unregulated performance-enhancing drugs, a properly supervised peptide plan is designed around your health history, lab results, goals, and tolerance

FDA-cleared procedure to safely target and remove diet and exercise resistant fat

Patients with one or more of these variant CYP2C9 alleles have decreased S-warfarin clearance (Table 1).2 Other CYP2C9 alleles associated with reduced enzymatic activity occur at lower frequencies, including *5, *6, and *11 alleles in populations of African ancestry and *5, *9 and *11 alleles in Caucasians

BPC-157 is not approved for human use by any regulatory agency